Numinus to Participate in the H.C. Wainwright Global Investment Conference on May 23-26, 2022
Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) will participate in a fireside chat at the H.C. Wainwright Global Investment Conference on May 25, 2022, at 3:30 p.m. ET. Founder and CEO Payton Nyquvest will discuss Numinus’ innovative mental health treatments, including psychedelic-assisted therapies. Attendees can register for the event here. The chat will also be available via live webcast and archived on Numinus’ investor relations website.
- None.
- None.
VANCOUVER, BC, May 11, 2022 /PRNewswire/ - Numinus Wellness Inc. ("Numinus") (TSX: NUMI) (OTC: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will participate in a fireside chat hosted by Patrick Trucchio, H.C. Wainwright Research Analyst, at the H.C. Wainwright Global Investment Conference to be held at the Fontainebleau Miami Beach Hotel in Miami, FL on Wednesday, May 25th at 3:30 p.m. ET.
To attend, please register here. In addition, the event will be available via live webcast and archived replay on Numinus' investor relations website at:
https://www.investors.numinus.com/events-and-presentations/default.aspx
For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please contact your appropriate H.C. Wainwright representative directly, or send an email to KCSA Strategic Communications NuminusIR@kcsa.com.
Numinus Wellness helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model – including psychedelic production, research and clinic care – is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.
Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.
Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.
View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-global-investment-conference-on-may-23-26-2022-301544872.html
SOURCE Numinus Wellness Inc.
FAQ
What is Numinus Wellness's upcoming event?
Who will represent Numinus at the conference?
What time is Numinus's presentation at the conference?
How can I watch the Numinus conference presentation?
Where is the H.C. Wainwright Global Investment Conference being held?
